SAShamima Akhter

Shamima Akhter

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shamima Akhter has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Abstract PO-049: The neural landscape is associated with functional outcomes for patients with oropharyngeal squamous cell carcinoma

    by Shajedul Islam, Frederico O. Gleber-Netto, Collin F. Mulcahy, Mica D. E. Glaun, Patrick J. Hunt, Michelle D. Williams, Carly E. Barbon, Weilu Zhao, Adewale Adebayo, Shamima Akhter, et al.

    Despite the excellent prognosis of patients with oropharyngeal squamous cell carcinoma (OPSCC), long-term functional impairment (e.g., dysphagia) is a major burden for many patients. Recent studies have explored the role of pharyngeal constrictors and muscle fibrosis in dysphagia. However, to date, no study has examined the association between the OPSCC neural microenvironment and posttreatment functional impairment. We hypothesized that cancer-related neuronal changes in the OPSCC tumor microenvironment (TME) would affect patients’ prognoses. Therefore, in the present study, we investigated whether cancer-related changes in the tumor neuronal microenvironment influence functional outcomes in patients with OPSCC. Prospectively collected, patient-reported outcomes (i.e., from the MD Anderson Symptom Inventory [MDASI] and the MD Anderson Dysphagia Inventory [MDADI]) and functional outcomes from the Dynamic Imaging Grade of Swallowing Toxicity [DIGEST] for patients with OPSCC were collected (n=29). OPSCC tissue samples were obtained from surgically treated patients, and multiplex/high-plex immunofluorescence and machine learning techniques were used to correlate neuronal changes with prospectively collected patient data. Electromyography was performed to assess the neuronal populations involved in neuropathies after treatment. A murine animal model of dysphagia was also used to correlate the neuronal changes. The results showed that sensory nerves with adrenergic features (CGRP+TH+) were associated with perineural and lymphovascular invasion. In addition, we found that human papillomavirus associated OPSCC was associated with an enrichment of parasympathetic progenitors (VIP+DCX+). Poor MDASI scores were associated with CGRP+, adrenergic (TH+), or CGRP+TH+ innervation, and growing progenitor neurons (GAP43+DCX+) were associated with improved oral symptoms. Swallowing, measured by MDADI scale revealed that patients with tumors enriched with growing (GAP43+), parasympathetic (VIP+), and neuronal progenitor (DCX+) neurons reported poor swallowing perception; subgroup electromyography analysis confirmed our findings. Quantitative swallowing assessment with DIGEST by speech language pathologists revealed that TMEs innervated by CGRP+, TH+, and MBP+ neurons were associated with poor swallowing functions. Finally, using a murine model of dysphagia we confirmed that sensory (CGRP+), myelinated (MBP+), and cholinergic parasympathetic (CHAT+) or progenitor (CHAT+DCX+) enrichment was associated with denervation and downstream dysphagia. In conclusion, our results show that neuronal changes are correlated with clinical features in OPSCC patients. Patients’ functional outcomes after therapy completion are influenced by distinct nerve populations in the TME. These benchmark data should be further evaluated as a potential target for cancer survivors with dysphagia and as a biomarker for patients who might need escalated swallowing rehabilitation during and after treatment for OPSCC. Citation Format: Shajedul Islam, Frederico O. Gleber-Netto, Collin F. Mulcahy, Mica D. E. Glaun, Patrick J. Hunt, Michelle D. Williams, Carly E. Barbon, Weilu Zhao, Adewale Adebayo, Shamima Akhter, Tongxin Xie, Ismail Yaman, Jared K. Burks, Javier Gomez, Karin Woodman, Teresa E. Lever, Katherine A. Hutcheson, Moran Amit. The neural landscape is associated with functional outcomes for patients with oropharyngeal squamous cell carcinoma [abstract]. In: Proceedings of the AACR-AHNS Head and Neck Cancer Conference: Innovating through Basic, Clinical, and Translational Research; 2023 Jul 7-8; Montreal, QC, Canada. Philadelphia (PA): AACR; Clin Cancer Res 2023;29(18_Suppl):Abstract nr PO-049.

  • Open Access

    Abstract PO-076: Adrenergic regulation of the anti-tumor immune response in p53-deficient tumors

    by Deborah A. Silverman, Shamima Akhter, Tongxin Xie, Shajedul Islam, Simone Anfossi, Jennifer D. Covello, Frederico O. Gleber-Netto, Elien Doorduijn, Yunfei Wang, Emily L. Ashkin, et al.

    Several previous studies have shown that β2-adrenergic signaling pathway promotes tumor progression, whereas others have shown the opposite effect. The role of β2-adrenergic activation in oral squamous cell carcinoma (OSCC) remains largely unknown. Our previous study showed that the loss of p53 leads to increased adrenergic tumor innervation in OSCC, resulting in transcriptional programs that establish new neuronal identity. We hypothesized that tumor immunity in OSCC is regulated by adrenergic signaling. The aim of the present study was to determine the influences of adrenergic signaling in immune microenvironment of OSCC. We first performed multiplex immunofluorescence to analyze the immune cell infiltration and adrenergic nerve density in OSCC; and analyzed the Cancer Genome Atlas (TCGA) datasets to establish correlations between immune-related and adrenergic pathway genes. Subsequently, we performed T cell killing assay with p53 knockout (KO) and p53 wild-type (WT) using antigen-specific HLA-matched patient-derived T-cells with adrenergic agonists or antagonists. To confirm p53-dependent adrenergic signaling in OSCC, a genetically engineered p53MDM2 overexpression (OE) cell line was generated and treated with adrenergic agonists or antagonists. To test our hypothesis that p53 regulates adrenergic-dependent paracrine signaling between cancer and T cells we performed a Luminex assay on the conditioned medium from p53KO and p53WT coculture system. Finally, in vivo, adrenergic ablation (THflox/flox) and novel murine models of OSCC were used to investigate the effect of adrenergic nerve signaling on immune infiltration and responses to immunotherapy. Our data showed that the increase in adrenergic nerve density was inversely proportional to the infiltration of exhausted T cells. Analysis of the TCGA data revealed that ADRB2 strongly correlated with tumor immune infiltrate genes. Adrenergic agonists treatment induced significantly more apoptosis in the p53KO but not in the p53WT cells; and overexpression of MDM2 rescued the resistance to apoptosis. Conditioned media experiments showed that the coculture of tumor cells with T cells acts through paracrine signaling and that the secreted factor is CXCL10. We then knocked out CXCL10 and ADRB2 in p53KO cells and confirmed that apoptosis was significantly reduced in the absence of CXCL10 or ADRB2. Genetic ablation of adrenergic signaling in vivo undermined response to anti-programmed cell death protein 1 (anti-PD1) compared to controls. Finally, our mouse model of OSCC showed that isoprenaline (β-adrenergic agonist) treatment in combination with PD-1 therapy significantly enhanced response to immunotherapy and improved survival. Our study provides new evidence that adrenergic signaling induces immune-mediated apoptosis and response to immunotherapy. Further studies are needed to assess the role of isoprenaline combined with anti-PD-1 therapy as a novel therapeutic regimen for patients with p53-deficient OSCC tumors. Citation Format: Deborah A. Silverman, Shamima Akhter, Tongxin Xie, Shajedul Islam, Simone Anfossi, Jennifer D. Covello, Frederico O. Gleber-Netto, Elien Doorduijn, Yunfei Wang, Emily L. Ashkin, Jeffrey N. Myers, George A. Calin, Patrick Hwu, Moran Amit. Adrenergic regulation of the anti-tumor immune response in p53-deficient tumors [abstract]. In: Proceedings of the AACR-AHNS Head and Neck Cancer Conference: Innovating through Basic, Clinical, and Translational Research; 2023 Jul 7-8; Montreal, QC, Canada. Philadelphia (PA): AACR; Clin Cancer Res 2023;29(18_Suppl):Abstract nr PO-076.

  • Open Access

    Factors Associated withKlebsiellaBacteremia and Its Outcome in Under-Five Children Admitted with Diarrhea

    by Shamima Akhter, Tahmeed Ahmed, Shafiqul Alam Sarker, Monira Sarmin, Abu S. M. S. B. Shahid, K. M. Shahunja, Shoeb Bin Islam, Lubaba Shahrin, Tahmina Alam, Nur Haque Alam, et al.

    AlthoughKlebsiellabacteremia in children is perceived to be associated with fatal consequences, data are scarce on those children presenting with diarrhea. We evaluated the factors associated withKlebsiellabacteremia in such children. In this retrospective chart analysis, data of all diarrheal children was retrieved from electronic medical record system (named as SHEBA) of Dhaka Hospital of International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), from January 1, 2010, to December 31, 2012, who had their blood culture done. This was a study having a case-control design where comparison of clinical and laboratory characteristics was done among children withKlebsiellabacteremia (cases = 30) and those without any bacteraemia (controls = 90). Controls were selected randomly. The cases more often had fatal outcome (p<0.001). In logistic regression analysis, after adjusting for potential confounders such as young age, severe dehydration, severe wasting, abnormal mentation, hypotension, and fast breathing, the cases were independently associated with hospital-acquired infection and positive stool growth (for all,p<0.05). The study highlights the importance of obtaining blood cultures in hospitalized children under five years old with diarrheal illness in the presence of either hospital-acquired infection or positive stool culture to have better outcome.